Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
9.35
+0.26 (2.86%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $682.43 million as of December 5, 2025. Its market cap has increased by 243.97% in one year.
Market Cap
682.43M
Enterprise Value
568.12M
1-Year Change
243.97%
Ranking
Category
Stock Price
$9.35
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $682.43M, an increase of 151.49%. That is a compound annual growth rate of 55.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 663.45M | 204.83% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 909.23B |
| Johnson & Johnson | 490.36B |
| AbbVie | 405.79B |
| UnitedHealth Group | 303.02B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 252.82B |
| Abbott Laboratories | 217.17B |